U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

RNAseq transcriptome profiling of melanoma cell lines

(Submitter supplied) The transcriptome of 55 cutaneous melanoma cell lines was assessed using RNAseq.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
55 Samples
Download data: CSV, XLSX
Series
Accession:
GSE140673
ID:
200140673
2.

63 Melanoma cell lines

(Submitter supplied) 63 melanoma cell lines hybridized to Affymetrix Hu133_Plus 2 oligo arrays. The aim of this study was to identify potential downstream targets of key oncogenes and TSGs in melanoma (including p14ARF, p16INK4A, BRAF etc). Publications relevant to this series include: Johansson et al. Pigment Cell Res 2007. Keywords: melanoma
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
63 Samples
Download data: CEL, CHP
Series
Accession:
GSE7127
ID:
200007127
3.

Human thyroid adenomas, carcinomas, and normals

(Submitter supplied) Human samples of various thyroid carcinomas, adenomas, and normals, each from a different patient, had mRNA assays performed using Affymetrix HG_U133A arrays, with 22283 probe-sets. The 99 samples consisted of 4 normals, 10 follicular adenomas, 13 follicular carcinomas, 7 oncocytic adenomas, 8 oncocytic carcinomas, 51 papillary carcinomas (each typed as having classical, follicular or tall cell morphology), 4 anaplastic carcinomas, and 2 medullary carcinomas. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
99 Samples
Download data: CEL, XLS
Series
Accession:
GSE27155
ID:
200027155
4.

Melanoma cell culture phenotypes I

(Submitter supplied) Recent trials with MAPK inhibitors have shown promising results in many patients with metastatic melanoma; however, nearly all responding patients experience disease relapse. We describe here how melanoma cells respond to MAPK inhibition in a phenotype-specific manner, suggesting that slow cycling invasive phenotype cells provide a treatment-resistant pool from which disease relapse may be derived. The implication is that while MAPK inhibition may successfully treat proliferating cells, another cell population needs to be addressed at the same time.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
12 Samples
Download data: CEL
Series
Accession:
GSE28335
ID:
200028335
5.

Genome-wide analysis of melanoma cell lines using high-density single-nucleotide polymorphism arrays.

(Submitter supplied) Although a number of genes related to melanoma development have been identified through candidate gene screening approaches, few studies have attempted to conduct such analyses on a genome-wide scale. Here we use Illumina 317K whole-genome single-nucleotide polymorphism arrays to define a comprehensive allelotype of melanoma based on loss of heterozygosity (LOH) and copy number changes in a panel of 76 melanoma cell lines. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; SNP genotyping by SNP array
Platform:
GPL5711
76 Samples
Download data
Series
Accession:
GSE9003
ID:
200009003
6.

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

(Submitter supplied) The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking is a systematic characterization of the regulatory relationships between genes whose expression is related to metastatic potential. Such a characterization would produce a molecular taxonomy for melanoma which could feasibly be used to identify epigenetic mechanisms behind changes in metastatic behaviour. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL97 GPL570 GPL96
105 Samples
Download data
Series
Accession:
GSE4845
ID:
200004845
7.

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature (Mannheim).

(Submitter supplied) The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking is a systematic characterization of the regulatory relationships between genes whose expression is related to metastatic potential. Such a characterization would produce a molecular taxonomy for melanoma which could feasibly be used to identify epigenetic mechanisms behind changes in metastatic behaviour. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
45 Samples
Download data
Series
Accession:
GSE4843
ID:
200004843
8.

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature (Philadelphia).

(Submitter supplied) The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking is a systematic characterization of the regulatory relationships between genes whose expression is related to metastatic potential. Such a characterization would produce a molecular taxonomy for melanoma which could feasibly be used to identify epigenetic mechanisms behind changes in metastatic behaviour. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
30 Samples
Download data
Series
Accession:
GSE4841
ID:
200004841
9.

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature (Zürich).

(Submitter supplied) The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking is a systematic characterization of the regulatory relationships between genes whose expression is related to metastatic potential. Such a characterization would produce a molecular taxonomy for melanoma which could feasibly be used to identify epigenetic mechanisms behind changes in metastatic behaviour. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL97 GPL96
30 Samples
Download data
Series
Accession:
GSE4840
ID:
200004840
10.

Genomic Profiling of Malignant Melanoma using tiling resolution array CGH

(Submitter supplied) Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and clinical outcome are needed. We searched for chromosomal aberrations that characterize its pathogenesis using 47 different melanoma cell lines and tiling-resolution BAC-arrays for comparative genomic hybridization. Major melanoma genes, including BRAF, NRAS, CDKN2A, TP53, CTNNB1, CDK4 and PTEN were examined for mutations. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4723
47 Samples
Download data: TXT
Series
Accession:
GSE6779
ID:
200006779
11.

Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL6102 GPL6947
79 Samples
Download data
Series
Accession:
GSE22155
ID:
200022155
12.

Gene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (validation set)

(Submitter supplied) Purpose: The incidence of malignant melanoma is increasing worldwide in fair-skinned populations. Melanomas respond poorly to systemic therapy, and metastatic melanomas inevitably become fatal. Although spontaneous regression, likely due to immune defense activation, rarely occurs, we lack a biological rationale and predictive markers in selecting patients for immune therapy. Experimental Design: We performed unsupervised hierarchical clustering of global gene expression data from stage IV melanomas in 57 patients. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6947
22 Samples
Download data: TXT
Series
Accession:
GSE22154
ID:
200022154
13.

Gene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (test set)

(Submitter supplied) Purpose: The incidence of malignant melanoma is increasing worldwide in fair-skinned populations. Melanomas respond poorly to systemic therapy, and metastatic melanomas inevitably become fatal. Although spontaneous regression, likely due to immune defense activation, rarely occurs, we lack a biological rationale and predictive markers in selecting patients for immune therapy. Experimental Design: We performed unsupervised hierarchical clustering of global gene expression data from stage IV melanomas in 57 patients. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6102
57 Samples
Download data: TXT
Series
Accession:
GSE22153
ID:
200022153
14.

Affymetrix 100K SNP array data-

(Submitter supplied) allele call files from analysis of NCI60 cell line DNA on 100K SNP arrays. Keywords = NCI60, SNP array, cancer cell line Keywords: other
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; SNP genotyping by SNP array
Platforms:
GPL2014 GPL2015
128 Samples
Download data: CEL
Series
Accession:
GSE2520
ID:
200002520
15.

Affymetrix 250K StyI SNP array data from PBMCs and cell lines of metastatic melanoma patients

(Submitter supplied) Allele call files from on 250K StyI SNP array using DNA from 60 human cell lines from metastasized melanoma and from 44 corresponding peripheral blood mononuclear cells (CEL and CHP files provided).
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; SNP genotyping by SNP array
Platform:
GPL3720
104 Samples
Download data: CEL, CHP
Series
Accession:
GSE17534
ID:
200017534
16.

Copy number analysis of human glioblastoma multiforme

(Submitter supplied) Copy number analysis of human GBM samples were performed, and a high frequency of deletions of the PTPRD gene on chromosome 9p23-24.1 were identified. Keywords: SNP microarray, glioblastoma multiforme, copy number, amplification, deletion
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platform:
GPL3718
58 Samples
Download data: CEL
Series
Accession:
GSE13021
ID:
200013021
17.

Human melanoma samples comparing nevi and primary and metastatic melanoma

(Submitter supplied) We sought to identify genes and gene signatures which correlate with progression by sampling human melanomas from nevi, primary, and metastatic tumors. The large number of samples also permits analysis within groups.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
121 Samples
Download data: CEL
Series
Accession:
GSE46517
ID:
200046517
18.

Human Melanoma vs Normal Human DNA

(Submitter supplied) Highly rearranged and mutated cancer genomes present major challenges in the identification of pathogenetic events driving the cancer process. Here, we engineered lymphoma-prone mice with chromosomal instability to assess the utility of mouse models in cancer gene discovery and the extent of cross-species overlap in cancer-associated copy number aberrations. Integrating with targeted re-sequencing, our comparative oncogenomic studies efficiently identified FBXW7 and PTEN as commonly deleted or mutated tumor suppressors in human T-cell acute lymphoblastic leukemia/lymphoma (T-ALL). more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL887
123 Samples
Download data: TXT
Series
Accession:
GSE7606
ID:
200007606
19.

Genome-Wide Analysis of Somatic Copy Number Alterations and Gene Expression in Metastatic Melanoma

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome variation profiling by SNP array; Genome variation profiling by genome tiling array
4 related Platforms
36 Samples
Download data: CEL, CSV, TXT
Series
Accession:
GSE23056
ID:
200023056
20.

Genome-Wide Analysis of Somatic Copy Number Alterations and Gene Expression in Metastatic Melanoma: RNA-Seq

(Submitter supplied) All cancers are diseases of the genome. A combination of somatic point mutations, focal amplifications and deletions, and chromosome level aberrations conspire to disrupt gene expression and the interplay between signaling pathways that control normal growth and tissue homeostasis. Here we investigate transcript levels in 7 melanomas and a pool of melanocytes.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL9186
8 Samples
Download data: TXT
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_674cc9ed30e6852f8a87fc39|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center